Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Acrivon Therapeutics, Inc. - Common Stock (NQ: ACRV ) 6.980 -0.020 (-0.29%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 93,083 Open 7.020 Bid (Size) 6.770 (2) Ask (Size) 7.400 (1) Prev. Close 7.000 Today's Range 6.860 - 7.180 52wk Range 3.190 - 11.90 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Acrivon Therapeutics Reports Positive Endometrial Cancer Data from Ongoing ACR-368 Registrational Intent Phase 2 Study at ESMO, Advancement of ACR-2316 into Clinic Ahead of Timelines, and Progress on its AP3 Interactome for Proprietary Data Analysis September 14, 2024 From Acrivon Therapeutics, Inc Via GlobeNewswire Acrivon Therapeutics to Present at the Cantor Global Healthcare Conference September 10, 2024 From Acrivon Therapeutics, Inc Via GlobeNewswire Performance YTD +39.32% +39.32% 1 Month -17.10% -17.10% 3 Month +19.11% +19.11% 6 Month -3.72% -3.72% 1 Year -22.44% -22.44% More News Read More Acrivon Therapeutics to Host Virtual Investor Event to Review Positive Phase 2 Clinical Data of ACR-368 Presented at ESMO and Pipeline Progress, Including Clinical Candidate ACR-2316 September 09, 2024 From Acrivon Therapeutics, Inc Via GlobeNewswire Acrivon Therapeutics: Q4 Earnings Insights March 28, 2024 Via Benzinga ACRV Stock Earnings: Acrivon Therapeutics Beats EPS for Q2 2024 August 13, 2024 Via InvestorPlace Acrivon Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights August 13, 2024 From Acrivon Therapeutics, Inc Via GlobeNewswire Acrivon Therapeutics to Present at the Jefferies Global Healthcare Conference May 29, 2024 From Acrivon Therapeutics, Inc Via GlobeNewswire ACRV Stock Earnings: Acrivon Therapeutics Beats EPS for Q1 2024 May 14, 2024 Via InvestorPlace Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights May 14, 2024 From Acrivon Therapeutics, Inc Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday April 25, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session April 24, 2024 Via Benzinga Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event April 24, 2024 From Acrivon Therapeutics, Inc Via GlobeNewswire Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316 April 16, 2024 From Acrivon Therapeutics, Inc Via GlobeNewswire Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon Predictive Precision Proteomics (AP3) for the Discovery of ACR-2316, a Novel, Selective WEE1/PKMYT1 Inhibitor, and the Identification of Actionable April 10, 2024 From Acrivon Therapeutics, Inc Via GlobeNewswire Crude Oil Down Over 1%; Cognyte Software Shares Plummet April 09, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 09, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session April 09, 2024 Via Benzinga Dow Dips 150 Points; Laser Photonics Shares Spike Higher April 09, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Is Rail Vision (RVSN) Stock Up 17% Today? April 09, 2024 Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence ACRV Stock Jumps 55% as Acrivon Therapeutics Gets $130 Million Boost April 09, 2024 Via InvestorPlace Acrivon Therapeutics Stock Is Soaring Tuesday: What's Going On? April 09, 2024 Via Benzinga Dow Gains Over 50 Points; Neogen Posts Downbeat Earnings April 09, 2024 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 09, 2024 Via Benzinga Acrivon Therapeutics Announces $130 Million Private Placement Financing April 09, 2024 From Acrivon Therapeutics, Inc Via GlobeNewswire ACRV Stock Earnings: Acrivon Therapeutics Misses EPS for Q4 2023 March 28, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
